Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Biotricity, Inc. (BTCY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8200-0.0700 (-2.42%)
At close: 04:00PM EST
3.2500 +0.42 (+14.84%)
After hours: 04:11PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.8900
Open2.9000
Bid2.7600 x 1100
Ask3.4900 x 800
Day's Range2.8000 - 2.9900
52 Week Range1.1300 - 5.3000
Volume300,476
Avg. Volume416,879
Market Cap138.543M
Beta (5Y Monthly)2.22
PE Ratio (TTM)N/A
EPS (TTM)-0.6780
Earnings DateFeb 09, 2022 - Feb 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.67
  • GuruFocus.com

    Cedar Mountain Advisors, LLC Buys ARK Innovation ETF, Berkshire Hathaway Inc, Ford Motor Co, ...

    Investment company Cedar Mountain Advisors, LLC (Current Portfolio) buys ARK Innovation ETF, Berkshire Hathaway Inc, Ford Motor Co, BTC iShares Core MSCI EAFE ETF, Vanguard Intermediate-Term Bond ETF, sells S&P 500 ETF TRUST ETF, iShares Russell 1000 ETF, iShares Emerging Markets Dividend ETF, Coinbase Global Inc, Alcoa Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Cedar Mountain Advisors, LLC.

  • ACCESSWIRE

    Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device

    Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmiasThe Biotres addresses the $2 Billion-dollar holter marketREDWOOD CITY, CA / ACCESSWIRE / January 24, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today reported it has received 510(k) clearance from the U.

  • ACCESSWIRE

    Biotricity Expands Distribution of New Bioheart Device on Amazon.com

    New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your SmartphoneNow Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle SolutionREDWOOD CITY, CA / ACCESSWIRE / December 28, 2021 /Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions, today announced it has expanded the distribution of its new Bioheart heart monitor system, a direct-to-consumer device that offers

Advertisement
Advertisement